Live from the NIH registry
Studies recruiting near Palmdale right now
Top 25 of 131 recruiting studies, sorted by proximity — each links to its official registry page
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 216 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: City of Hope Medical Center
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Olive View UCLA Medical Center /ID# 259092 — Sylmar, California (27.8 mi)
· Sponsor: AbbVie
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
Phase 2
Interventional 29 participants sought
City of Hope at Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: City of Hope Medical Center
Aveir DR Real-World Evidence Post-Approval Study
Cardiac Pacemaker, Arrythmia
N/A
Observational 1,805 participants sought
Abbott — Sylmar, California (27.8 mi)
· Sponsor: Abbott Medical Devices
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Om Research, LLC — Lancaster, California (7.4 mi)
· Sponsor: Boehringer Ingelheim
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Hoffmann-La Roche
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8
Phase 2
Interventional 535 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: City of Hope Medical Center
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 19 — Palmdale, California (1.2 mi)
· Sponsor: BioStem Technologies
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Phase 2
Interventional 270 participants sought
Amicis Research Center — Santa Clarita, California (28.6 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Lancaster, California (7.4 mi)
· Sponsor: 89bio, Inc.
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Om Research, LLC 1 — Lancaster, California (7.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Ulcerative Colitis, Inflammatory Bowel Diseases
Phase 2
Interventional 645 participants sought
Site 012 — Lancaster, California (7.4 mi)
· Sponsor: Spyre Therapeutics, Inc.
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Sylmar, California (27.8 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
USC Norris Santa Clarita Oncology — Santa Clarita, California (28.6 mi)
· Sponsor: NRG Oncology
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Tujunga, California (25.8 mi)
· Sponsor: GlaxoSmithKline
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Phase 3
Interventional 990 participants sought
Chemidox Clinical Trials Inc, Merz Investigational Site #0010488 — Lancaster, California (7.4 mi)
· Sponsor: Merz Therapeutics GmbH
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Psoriatic Arthritis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Medvin Clinical Research - Tujunga — Tujunga, California (25.8 mi)
· Sponsor: Eli Lilly and Company
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Amicis Research Corporate — Santa Clarita, California (28.6 mi)
· Sponsor: Boehringer Ingelheim
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400006 — Lancaster, California (7.4 mi)
· Sponsor: Sanofi
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Lancaster, California (7.4 mi)
· Sponsor: Alnylam Pharmaceuticals
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 980 participants sought
Om Research, LLC - Lancaster - Site Number: 8400148 — Lancaster, California (7.4 mi)
· Sponsor: Sanofi
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Alopecia Areata
Phase 2
Interventional 60 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (28.6 mi)
· Sponsor: Eli Lilly and Company
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
First Valley Medical Group — Lancaster, California (7.4 mi)
· Sponsor: Novo Nordisk A/S
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Vitiligo, Non-Segmental Vitiligo (NSV)
Phase 2
Interventional 66 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (28.6 mi)
· Sponsor: Eli Lilly and Company